These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 148966)

  • 1. Radioimmunoassay for the detection and quantitation of 5-fluorodexoyuridine.
    Schreiber R; Raso V
    Cancer Res; 1978 Jul; 38(7):1889-92. PubMed ID: 148966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A rapid and specific radioimmunoassay for methotrexate.
    Raso V; Schreiber R
    Cancer Res; 1975 Jun; 35(6):1407-10. PubMed ID: 1079473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new radioimmunoassay for haloperidol: direct measurement of serum and striatal concentrations.
    Wurzburger RJ; Miller RL; Marcum EA; Colburn WA; Spector S
    J Pharmacol Exp Ther; 1981 Jun; 217(3):757-63. PubMed ID: 7230004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of an antibody to actinomycin D and its application for the detection of serum levels by radioimmunoassay.
    Brothman AR; Davis TP; Duffy JJ; Lindell TJ
    Cancer Res; 1982 Mar; 42(3):1184-7. PubMed ID: 6174214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms of potentiation of antitumor activity of 5-fluoro-2'-deoxyuridine in the adenocarcinoma 755 system by guanosine 5'-monophosphate.
    Iigo M; Yamaizumi Z; Nakajima Y; Nishimura S; Hoshi A
    Drugs Exp Clin Res; 1988; 14(4):257-63. PubMed ID: 2458897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrolysis of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine (FdUrd-C8) in rabbit and human plasma and its release from oily solution.
    Fukushima S; Hayashi Y; Kawaguchi T; Kaneko M; Nakano M
    J Pharmacobiodyn; 1989 Aug; 12(8):495-502. PubMed ID: 2559183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective accumulation of 3',5'-dioctanoyl-5-fluoro-2'-deoxyuridine (FdUrd-C8) and sustained release of its active metabolites in VX-2 rabbit hepatoma following intraarterial administration of FdUrd-C8 solution in Lipiodol.
    Kawaguchi T; Fukushima S; Hayashi Y; Kaneko M; Nakano M
    Cancer Res; 1988 Aug; 48(15):4179-83. PubMed ID: 2839289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of tiamenidine in biological specimens by radioimmunoassay.
    Eckert HG; Baudner S; Weimer KE; Wissmann H
    Arzneimittelforschung; 1981; 31(3):419-24. PubMed ID: 7194666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Simultaneous quantification of 5-FU, 5-FUrd, 5-FdUrd, 5-FdUMP, dUMP and TMP in cultured cell models by LC-MS/MS.
    Carli D; Honorat M; Cohen S; Megherbi M; Vignal B; Dumontet C; Payen L; Guitton J
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Oct; 877(27):2937-44. PubMed ID: 19620028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alteration of fluorouracil metabolism in human colon cancer cells by dipyridamole with a selective increase in fluorodeoxyuridine monophosphate levels.
    Grem JL; Fischer PH
    Cancer Res; 1986 Dec; 46(12 Pt 1):6191-9. PubMed ID: 2946402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nucleotide levels and incorporation of 5-fluorouracil and uracil into DNA of cells treated with 5-fluorodeoxyuridine.
    Ingraham HA; Tseng BY; Goulian M
    Mol Pharmacol; 1982 Jan; 21(1):211-6. PubMed ID: 6215571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A radioimmunoassay for 5-methyltetrahydrohomofolate.
    Fong KL; Ho DH; Benjamin RS; Yang F; Sickler J; Brown NS; Bodey GP
    J Pharmacol Exp Ther; 1981 Aug; 218(2):344-7. PubMed ID: 6265623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-Fluoro-2'-deoxyuridine elimination by the isolated perfused rat liver.
    Csaky KG; LaCreta FP; Warren BS; Williams WM
    Cancer Res; 1988 Jul; 48(13):3561-5. PubMed ID: 2967734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Theophylline radioimmunoassay: synthesis of antigen and characterization of antiserum.
    Cook CE; Twine ME; Myers M; Amerson E; Kepler JA; Taylor GF
    Res Commun Chem Pathol Pharmacol; 1976 Mar; 13(3):497-505. PubMed ID: 935638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of 5-fluoro-2'-deoxyuridine (FdUrd) on 5-bromo-2'-deoxyuridine (BrdUrd) incorporation into DNA measured with a monoclonal BrdUrd antibody and by the BrdUrd/Hoechst quenching effect.
    Ellwart J; Dörmer P
    Cytometry; 1985 Nov; 6(6):513-20. PubMed ID: 2415309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The production and characterization of antibodies reactive with meperidine.
    Wainer BH; Wung WE; Hill JH; Fitch FW; Fried J; Rothberg RM
    J Pharmacol Exp Ther; 1976 Jun; 197(3):734-43. PubMed ID: 945349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenobarbital specific antibody production: preparation of 5-phenyl-5-(4-aminobutyl) barbituric acid-bovine serum albumin conjugate.
    Castro A; Chung A; Monji N
    Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):309-17. PubMed ID: 7394326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase I and pharmacologic evaluation of intraperitoneal 5-fluoro-2'-deoxyuridine.
    Muggia FM; Chan KK; Russell C; Colombo N; Speyer JL; Sehgal K; Jeffers S; Sorich J; Leichman L; Beller U
    Cancer Chemother Pharmacol; 1991; 28(4):241-50. PubMed ID: 1831736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of pyrimidine nucleoside phosphorylase inhibitors on hepatic fluoropyrimidine elimination in the rat.
    LaCreta FP; Warren BS; Williams WM
    Cancer Res; 1989 May; 49(10):2567-73. PubMed ID: 2523758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
    Jackman AL; Alison DL; Calvert AH; Harrap KR
    Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.